150 related articles for article (PubMed ID: 19823804)
1. Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder.
Bell C; Hood S; Potokar J; Nash J; Adrover M; Frampton C; Hince D; Rich A; Argyropoulos S; Nutt D
Psychopharmacology (Berl); 2011 Feb; 213(2-3):593-602. PubMed ID: 19823804
[TBL] [Abstract][Full Text] [Related]
2. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
[TBL] [Abstract][Full Text] [Related]
3. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
Ströhle A; Kellner M; Holsboer F; Wiedemann K
Biol Psychiatry; 1999 Feb; 45(3):321-6. PubMed ID: 10023509
[TBL] [Abstract][Full Text] [Related]
4. Flumazenil challenge in social phobia.
Coupland NJ; Bell C; Potokar JP; Dorkins E; Nutt DJ
Depress Anxiety; 2000; 11(1):27-30. PubMed ID: 10723632
[TBL] [Abstract][Full Text] [Related]
5. Effects of the benzodiazepine antagonist flumazenil in PTSD.
Randall PK; Bremner JD; Krystal JH; Nagy LM; Heninger GR; Nicolaou AL; Charney DS
Biol Psychiatry; 1995 Sep; 38(5):319-24. PubMed ID: 7495926
[TBL] [Abstract][Full Text] [Related]
6. Effect of single doses of pindolol and d-fenfluramine on flumazenil-induced anxiety in panic disorder patients.
Bernik M; Ramos RT; Hetem LAB; Graeff F
Behav Brain Res; 2019 Jan; 357-358():82-87. PubMed ID: 29113874
[TBL] [Abstract][Full Text] [Related]
7. Response to flumazenil in women with premenstrual dysphoric disorder.
Le Mellédo JM; Van Driel M; Coupland NJ; Lott P; Jhangri GS
Am J Psychiatry; 2000 May; 157(5):821-3. PubMed ID: 10784479
[TBL] [Abstract][Full Text] [Related]
8. Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users.
Bernik MA; Gorenstein C; Vieira Filho AH
J Psychopharmacol; 1998; 12(2):146-50. PubMed ID: 9694026
[TBL] [Abstract][Full Text] [Related]
9. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients.
Schruers K; Klaassen T; Pols H; Overbeek T; Deutz NE; Griez E
Psychiatry Res; 2000 Apr; 93(3):179-87. PubMed ID: 10760376
[TBL] [Abstract][Full Text] [Related]
10. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.
Nutt DJ; Glue P; Lawson C; Wilson S
Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449
[TBL] [Abstract][Full Text] [Related]
11. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder.
Woods SW; Charney DS; Silver JM; Krystal JH; Heninger GR
Psychiatry Res; 1991 Feb; 36(2):115-27. PubMed ID: 1850142
[TBL] [Abstract][Full Text] [Related]
12. Extinction of panicogenic effects of a 35% CO2 challenge in patients with panic disorder.
Schmidt NB; Trakowski JH; Staab JP
J Abnorm Psychol; 1997 Nov; 106(4):630-8. PubMed ID: 9358693
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.
Tõru I; Shlik J; Maron E; Vasar V; Nutt DJ
Psychopharmacology (Berl); 2006 May; 186(1):107-12. PubMed ID: 16541242
[TBL] [Abstract][Full Text] [Related]
14. Internet-versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial.
Bergström J; Andersson G; Ljótsson B; Rück C; Andréewitch S; Karlsson A; Carlbring P; Andersson E; Lindefors N
BMC Psychiatry; 2010 Jul; 10():54. PubMed ID: 20598127
[TBL] [Abstract][Full Text] [Related]
15. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.
Klaassen T; Klumperbeek J; Deutz NE; van Praag HM; Griez E
Psychiatry Res; 1998 Feb; 77(3):167-74. PubMed ID: 9707299
[TBL] [Abstract][Full Text] [Related]
16. Effect of flumazenil in lactate-sensitive patients with panic disorder.
Ströhle A; Kellner M; Yassouridis A; Holsboer F; Wiedemann K
Am J Psychiatry; 1998 May; 155(5):610-2. PubMed ID: 9585710
[TBL] [Abstract][Full Text] [Related]
17. Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study.
Applebaum J; Bersudsky Y; Klein E
Bipolar Disord; 2007 Dec; 9(8):884-7. PubMed ID: 18076538
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
[TBL] [Abstract][Full Text] [Related]
19. Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.
Bradwejn J; Koszycki D; Couëtoux du Tertre A; Paradis M; Bourin M
Psychopharmacology (Berl); 1994 Mar; 114(2):257-61. PubMed ID: 7838917
[TBL] [Abstract][Full Text] [Related]
20. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.
Aaronson CJ; Shear MK; Goetz RR; Allen LB; Barlow DH; White KS; Ray S; Money R; Saksa JR; Woods SW; Gorman JM
J Clin Psychiatry; 2008 Mar; 69(3):418-24. PubMed ID: 18278989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
